Streetbeat News

Products Services

TTWO

Rockstar Games, a subsidiary of Take-Two Interactive Software, Inc. (TTWO), experienced a leak of their trailer, prompting them to direct audiences to watch the official version on YouTube. The company addressed the situation via a Twitter post.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:21 pm

VNDA

Vanda Pharmaceuticals announced that the FDA has accepted its New Drug Application for Tradipitant, aimed at treating Gastroparesis. The FDA's decision is expected by September 18, 2024. If approved, Tradipitant would be the first novel drug for Gastroparesis approved in over 40 years.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:02 pm

ETCUSD

ETHUSD

The article discusses Ethereum's (ETH) potential to make investors millionaires if it returns to its all-time high. Ethereum, launched in 2015, has seen significant events like the Ethereum 2.0 fork, interest in NFTs, and a transition from proof-of-work to proof-of-stake. Despite the 2022 crypto company bankruptcies, Ethereum's price is up 12% over the last week and 80% YTD in 2023. To become a millionaire at Ethereum's all-time high, an investor would need 204.43 ETH, costing $456,338.87 today. However, there's no guarantee of Ethereum's price increase.

Portfolio Pulse from Chris Katje

December 04, 2023 | 10:12 pm

NPCE

NeuroPace has entered into a strategic collaboration to provide biomarker monitoring and data analysis capabilities using its RNS System. A clinical-stage biotechnology company will pay NeuroPace up to $3.7 million over two years for non-exclusive access to these services for its clinical trial patients.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:09 pm

NPCE

NeuroPace, Inc. has entered into a collaboration with Rapport Therapeutics to share site data for Rapport's Phase 2a trial of their GABA A receptor-associated protein compound.

Portfolio Pulse from Charles Gross

December 04, 2023 | 10:09 pm

CTSH

The University of Melbourne has selected Cognizant (CTSH) to develop data-driven and personalized experiences for students, staff, and alumni to improve engagement.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:01 pm

IDT

IDT Corporation expressed optimism about its positioning as it enters Q2 of FY24, with plans to continue opportunistic share repurchases. The company anticipates that net2phone AI and upcoming premium plans will contribute to significant ARPU (average revenue per user) and margin growth.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:49 pm

TSLA

Tesla Inc (NASDAQ:TSLA) has launched the Cybertruck For Kids, a $1,500 all-electric, four-wheel ride-on toy inspired by the Cybertruck. It seats two children aged 6-12, has a weight limit of 150 pounds, and can reach speeds up to 10 mph. The toy has a range of 12 miles and is currently sold out, with Tesla planning to begin shipping in late December 2023. This follows the previous release and recall of the Cyberquad for Kids.

Portfolio Pulse from Chris Katje

December 04, 2023 | 9:42 pm

ATHE

Alterity Therapeutics will host a webcast to discuss the efficacy data of ATH434 in primates and recent clinical progress. The webcast, led by CEO Dr. David Stamler, is scheduled for 6 December 2023 in Australia and 5 December 2023 in the US. Investors need to register to attend and can submit questions in advance.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:35 pm

JNJ

The U.S. FDA has granted Breakthrough Therapy Designation (BTD) to Johnson & Johnson's TAR-200 for the treatment of high-risk non-muscle-invasive bladder cancer (HR-NMIBC). TAR-200 is an investigational targeted releasing system for sustained local release of gemcitabine. The designation is based on data from the ongoing Phase 2b SunRISe-1 study, which also evaluates cetrelimab, a PD-1 monoclonal antibody. The BTD aims to expedite the development and review of treatments for serious conditions showing substantial improvement over existing therapies.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:33 pm